Sabby Management, LLC Aslan Pharmaceuticals LTD Transaction History

Sabby Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.36 - $24.24 $53,404 - $3.6 Million	-148,345 Reduced 29.73%	350,700 $126,000
Q3 2022 Nov 14, 2022	SELL	$0.42 - $24.68 $168,401 - $9.9 Million	-400,955 Reduced 44.55%	499,045 $299,000
Q2 2022 Aug 15, 2022	SELL	$0.36 - $0.9 $11,663 - $29,159	-32,399 Reduced 3.47%	900,000 $446,000
Q1 2022 May 16, 2022	BUY	$0.74 - $1.22 $24,086 - $39,709	32,549 Added 3.62%	932,399 $839,000
Q4 2021 Feb 14, 2022	BUY	$1.11 - $1.86 $234,709 - $393,297	211,450 Added 30.72%	899,850 $1.01 Million
Q3 2021 Nov 15, 2021	SELL	$1.78 - $3.41 $136,839 - $262,147	-76,876 Reduced 10.05%	688,400 $1.23 Million
Q2 2021 Aug 16, 2021	SELL	$2.5 - $3.72 $129,722 - $193,027	-51,889 Reduced 6.35%	765,276 $2.53 Million
Q1 2021 May 17, 2021	BUY	$1.86 - $5.25 $1.52 Million - $4.29 Million	817,165 New	817,165 $2.74 Million

Ticker ASLN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,744,704
Market Cap $41.8M
Description
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-m...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.